Coya Therapeutics Future Growth
Future criteria checks 2/6
Coya Therapeutics's earnings are forecast to decline at 30.1% per annum while its annual revenue is expected to grow at 22.7% per year. EPS is expected to decline by 22.2% per annum.
Key information
-30.1%
Earnings growth rate
-22.2%
EPS growth rate
| Biotechs earnings growth | 28.5% |
| Revenue growth rate | 22.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Companies Like Coya Therapeutics (NASDAQ:COYA) Can Afford To Invest In Growth
Oct 29
Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts
Oct 13Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans
Mar 26Coya Therapeutics In Catbird Seat Following Dr. Reddy's Licensing Deal
Feb 13Coya Therapeutics: Interesting Early Data In CNS Diseases, Very Low Cash Position
Jan 13We Think Coya Therapeutics (NASDAQ:COYA) Needs To Drive Business Growth Carefully
Sep 06Here's Why We're Watching Coya Therapeutics' (NASDAQ:COYA) Cash Burn Situation
May 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10 | -22 | -31 | -21 | 1 |
| 12/31/2025 | 6 | -22 | -22 | -22 | 4 |
| 12/31/2024 | 4 | -17 | -22 | -15 | 4 |
| 9/30/2024 | 10 | -11 | -10 | -10 | N/A |
| 6/30/2024 | 10 | -10 | -7 | -7 | N/A |
| 3/31/2024 | 6 | -10 | -6 | -5 | N/A |
| 12/31/2023 | 6 | -8 | -12 | -11 | N/A |
| 9/30/2023 | N/A | -12 | -12 | -11 | N/A |
| 6/30/2023 | N/A | -13 | -11 | -11 | N/A |
| 3/31/2023 | N/A | -13 | -10 | -9 | N/A |
| 12/31/2022 | N/A | -12 | -8 | -7 | N/A |
| 9/30/2022 | N/A | -11 | -6 | -6 | N/A |
| 6/30/2022 | N/A | -8 | -6 | -6 | N/A |
| 3/31/2022 | N/A | -6 | -5 | -5 | N/A |
| 12/31/2021 | N/A | -5 | -4 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COYA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: COYA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: COYA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: COYA's revenue (22.7% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: COYA's revenue (22.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COYA's Return on Equity is forecast to be high in 3 years time